Open Access<p>Is There a Survival Benefit for Patients with Advanced Ovarian Clear Cell Carcinoma Who Complete More Than 6 Cycles of Postoperative Chemotherapy?</p>
Author(s) -
Jing Wang,
Yuying Shi,
Yan Liu,
Wei Li,
Hong Jiang,
Hongwei Cai
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s280141
Subject(s) - medicine , debulking , chemotherapy , clear cell carcinoma , stage (stratigraphy) , adjuvant , oncology , multivariate analysis , retrospective cohort study , overall survival , carcinoma , surgery , gastroenterology , urology , ovarian cancer , cancer , paleontology , biology
To provide a reference for clinicians, whether patients with advanced ovarian clear cell carcinoma (OCCC) require chemotherapy (CT) for more than 6 cycles after tumor debulking.